OHB SE O.N.
Commented by Stefan Bode on September 4th, 2026 | 10:40 CEST
Billion-Dollar Contracts, Takeover Battle and 600% Upside Potential: Where the Action Is Now - Frasers Group, Hugo Boss, MustGrow Biologics, OHB
Created and Published on Behalf of MustGrow Biologics Corp.
Pure excitement and volatility on the international financial markets. While an established, long-standing group faces a change in control following a takeover bid and a battle for majority voting rights, an emerging niche player is celebrating its first-ever quarterly profit following a groundbreaking deal with a major player in the agricultural sector. At the same time, a high-profile technology leader is showing that even significant billion-dollar contracts offer no guarantee of a rising share price. Three highly exciting companies from different sectors offer unique opportunities for your investment portfolio.
Read
Commented by Matthias Schomber on September 4th, 2026 | 09:30 CEST
Danger at Rheinmetall and OHB! Is HPQ Silicon a Buying Opportunity?
The defence sector has experienced an unprecedented rally in recent years, but a harsher wind is suddenly blowing on the trading floor. While major players such as Rheinmetall and the aerospace specialist OHB are suffering from profit-taking and rising oil prices despite their exceptionally strong order books, a potentially entirely new opportunity is emerging away from the headlines. Canadian technology company HPQ Silicon is developing market-changing innovations in battery and hydrogen technologies that are approaching commercial breakthrough. Bold investors who think innovatively may recognize that opportunities on the stock market could be emerging right now.
Read
Commented by Fabian Lorenz on September 2nd, 2026 | 07:20 CEST
Is It Time to Sell Gerresheimer? Aerospace and Gold Contenders Step Into the Spotlight: OHB and Lahontan Gold in Focus
A major coup for OHB. Germany's space industry hopeful has secured a contract worth billions. Could this also give the share price another boost? Even its inclusion in the SDAX failed to halt the sharp correction. The gold price is currently performing strongly once again. As such, the timing for Lahontan Gold shares could hardly be better. The exploration company is currently taking the final steps toward becoming a producer. The mine is set to be built in the US state of Nevada next year. The resource estimate was recently raised to 2.4 million ounces, and management sees plenty more potential. Is the rally at Gerresheimer, up over 50%, now coming to an end? The group, battered by profit warnings, costly takeovers and accounting issues, is working on a comeback. Yet analysts are advising "Sell".
Read
Commented by Fabian Lorenz on August 11th, 2026 | 07:15 CEST
Sell Rheinmetall Shares? Over 20% Gains in One Week! Buy Rating for OHB! Bayer Partner MustGrow Begins Re-Rating
Created and Published on Behalf of MustGrow Biologics Corp.
MustGrow Biologics shares climbed more than 20% last week, potentially marking the beginning of a long-awaited re-rating. Analysts believe significantly higher prices are achievable. Revenue is expected to multiply over the coming years, with the company also targeting substantial profitability. MustGrow could also benefit from milestone payments from its partner, Bayer. These potential payments are not included in current analyst estimates, potentially providing additional upside. At Rheinmetall, analysts are lowering their 2028 revenue estimates. Experts also see risks regarding cash flow and margins. As a result, they have downgraded the shares of Germany's largest defence contractor from "Hold" to "Sell." Analysts are considerably more optimistic about OHB. A key element of the investment case is the expectation that the German space-industry hopeful will secure major contracts over the coming months.
Read
Commented by Fabian Lorenz on July 16th, 2026 | 07:00 CEST
100% Upside Potential, a Downgrade, and a Sell-Off: Renk, OHB, and Almonty
Analysts see around 100% upside potential in shares of Almonty Industries. Following discussions with the company's CEO, they have raised both their earnings estimates and their price target to USD 33. Even under what they describe as conservative assumptions, the stock is expected to trade at a 2027 P/E ratio of below 10. Analysts are less optimistic about Renk Group. While the transmission manufacturer is expected to deliver solid growth, its valuation is no longer considered attractive. In addition, the long-term shift in defense procurement from tanks toward drones could become a headwind for the company. As a result, the stock has been downgraded. The situation at OHB is even more dramatic. The aerospace company's shares have fallen by more than 50% in roughly two months. Following the recently completed capital increase, investors are now expected to refocus on the company's underlying operational performance.
Read
Commented by Fabian Lorenz on July 8th, 2026 | 07:00 CEST
Stock Poised for Multi-Bagger Gains? Rheinmetall, OHB, and MustGrow Under the Analyst Microscope
Created and published on behalf of MustGrow Biologics Corp.
Is Rheinmetall's frigate setback only half as bad as it first appeared? While analysts have trimmed their revenue forecasts, they generally view the overall impact as manageable and continue to recommend the stock as a Buy. For MustGrow's stock, some analysts even see multi-bagger potential. The Canadian company aims to transform agriculture with its mustard-based biological crop protection products. Commercial rollout is now underway, with revenue and earnings expected to grow significantly over the coming years. Its partnership with Bayer is expected to provide additional upside potential. Meanwhile, OHB's capital increase concludes today. Shares in the German space company have come under significant pressure in recent weeks. Although analysts continue to recommend the stock as a buy, they see only limited upside from current levels, while the valuation remains demanding.
Read
Commented by Fabian Lorenz on July 6th, 2026 | 07:15 CEST
TKMS Ahead of Billion-Euro Deal! AI Fantasy at OHB and Schwarz Digits! Buying Opportunity at Drone Specialist Volatus Aerospace!
TKMS is seen as the big winner of Rheinmetall's debacle around the F126 frigate programme. After the German government pulled the plug, the new frigate deal could now move very quickly. According to "hartpunkt.de", the Bundestag is set to decide on the order of four new frigates from TKMS before the summer recess. Like the entire defence sector, drone stocks are not among investors' favourites this year either. But given the future prospects in the military and civilian arenas, it can really only be a matter of time before the rally starts again. A hot buy candidate is Volatus Aerospace. The Canadians are benefiting from NATO contracts, have just opened a new site and have a full pipeline. OHB's shares recently crashed. The German space company had previously benefited from the SpaceX hype. Then a capital increase triggered a sell-off. Can the AI partnership with Schwarz Digits generate fresh price fantasy?
Read
Commented by André Will-Laudien on June 29th, 2026 | 07:10 CEST
Gold, Defense, Aerospace: Sector Rotation in Full Swing – SpaceX, OHB, Desert Gold, Rheinmetall, and TKMS
Stock markets remain surprisingly resilient as the end of June approaches, but the glossy surface is starting to fade in certain segments. The bull market in aerospace is losing steam, and in the defense sector, after many months of gains, profit-taking is now becoming noticeable. As a result, valuations are gradually re-aligning with fundamentals. For rational investors, market hype is difficult to reconcile with, but one thing remains clear: stocks that become excessively overvalued tend to correct sharply when expectations are pushed to extreme levels without sufficient justification. Just as with Elon Musk's inflated initial valuation, the exit bell has likely rung quite loudly for Rheinmetall as well. In the fall, analysts had been outbidding each other with price targets around EUR 2,200; now they are painfully backtracking. Price declines of 20% in just a few trading hours for the defence sector star, and a 30% drop from its peak for SpaceX. But there are other hot candidates worth a closer look. OHB is drawing attention following a significant capital increase, while TKMS has secured a major naval contract. These developments are actively reshaping market dynamics—we break down what it means in detail.
Read
Commented by Fabian Lorenz on June 29th, 2026 | 06:50 CEST
OHB Caught in the SpaceX Trap! Buy Rheinmetall Now? Almonty Shares Added to the Russell Index Today - Tungsten Outperforms Gold!
Rheinmetall has had a disastrous week. The stock of Germany's largest defense contractor has lost more than 20% over the past five trading days. Is this a buying opportunity? What do analysts say? OHB's stock plummeted by over 30% last week. The German aerospace company shocked shareholders with a major capital increase and the partial exit of a major shareholder. Furthermore, the space hype surrounding the SpaceX IPO appears to be over. Still, the stock is up over 100% so far in 2026. Almonty shares have posted similarly strong gains in 2026. The price of this tungsten high-flyer also consolidated last week. However, the price of tungsten remains at an all-time high. More and more media outlets are reporting on shortages of this critical raw material—even in China. Almonty should continue to benefit from this trend. Incidentally, as of today, the stock is part of the Russell 1000 and 3000 indices.
Read
Commented by Carsten Mainitz on June 17th, 2026 | 06:55 CEST
Space Exploration, Drones, and Critical Raw Materials: Positioned for Success with OHB, Rheinmetall, and Antimony Resources
Created and published on behalf of Antimony Resources Corp.
The prospect of an end to the conflict between the US and Iran has fueled investor optimism, yet many critical details remain unresolved. The formal "framework agreement" is scheduled to be signed in Geneva this Friday. However, looking back at the volatility of recent months, valid doubts remain as to whether this will mark a definitive breakthrough or if a significant gap will once again emerge between communicated "facts" and on-the-ground reality. Stocks in the defence and critical raw materials sectors retain a unique appeal for investors, especially given that valuations have recently experienced a notable pullback. The broader picture remains intact, and demand conditions are equally supportive. Through the three featured companies, investors can position themselves across distinct segments of this broader investment landscape. Antimony Resources is uniquely positioned to benefit from the surging strategic importance of the critical mineral antimony and a highly precarious supply deficit, which serves as a powerful long-term catalyst for shareholder returns.
Read